Prostate cancer news reports: Friday, June 5, 2009

Today’s news reports refer to a series of reviews that appeared this month in a supplement to Urology as well as other articles:

  • 20 years of experience with the PSA test in assessment of risk for prostate cancer
  • Biomarkers in the assessment of future risk for prostate cancer
  • Treatment choice, outcome, and quality of life
  • Using PSA to assess overall survival in CRPC
  • Prognosis of death in hormonally treatment men with metastatic prostate cancer … READ MORE …

The clinical relevance of new biomarkers is tricky

Assiduous readers of this blog will have noted that there are relatively frequent mentions of “new” biomarkers that may have potential as indicators of the aggressiveness of prostate cancer — but that in most cases those biomarkers are never heard of again. … READ MORE …

The prostate cancer news report: Tuesday, May 5, 2009

We are returning to “normal” today with the standard “news reports.” Today’s items deal with:

  • Evolving biomarkers and new tests and their future application
  • MRI in diagnosis, staging, and prognosis of prostate cancer
  • Intraprostatic injection of LHRH agonists and antagonists: is it viable?
  • Gefitinib in HRPC: no evident impact on quality of life … READ MORE …

The Friday news reports (Part B): February 13, 2009

The second set of reports in today’s news commentaries encompasses new nomograms, possible new biomarkers, a specific subtype of prostate cancer, and the “hedgehog” signaling pathway. … READ MORE …

The weekend prostate cancer news: October 25, 2008

Some interesting new reports today include:

  • An update on the Prostate Cancer Prevention Trial
  • Early data on the potential of a traditional Chinese herbal medication
  • Predictive value of PSA velocity in management of low-risk patients with low-dose brachytherapy
  • Reviews of emerging biomarkers and the role(s) of MRI … READ MORE …

Prostate cancer reports from ASTRO, no. 2

Prostate cancer reports from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), being held in Boston, are kindly provided by Eyad Abu-Isa, MD, a resident in radiation oncology at the University of Michigan.

Most of the prostate cancer data presented in today’s scientific sessions were from retrospective reviews and the afternoon genitourinary session was focused on biomarkers and predictors of outcome in prostate cancer. … READ MORE …